Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Acute myeloid leukemia
|
Copanlisib Copanlisib 💬Acute myeloid leukemia
| Copanlisib | 121 [1] 121 💬1. Acute myeloid leukemia
|
||||||||||||||
2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬AGE-RAGE signaling pathway in diabetic complications
|
Copanlisib Copanlisib 💬AGE-RAGE signaling pathway in diabetic complications
| Copanlisib | 121 [1] 121 💬2. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||
3 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Aldosterone-regulated sodium reabsorption
|
Copanlisib Copanlisib 💬Aldosterone-regulated sodium reabsorption
| Copanlisib | 121 [1] 121 💬3. Aldosterone-regulated sodium reabsorption
|
||||||||||||||
4 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Alzheimer disease
|
Copanlisib Copanlisib 💬Alzheimer disease
| Copanlisib | 121 [1] 121 💬4. Alzheimer disease
|
||||||||||||||
5 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Amoebiasis
|
Copanlisib Copanlisib 💬Amoebiasis
| Copanlisib | 121 [1] 121 💬5. Amoebiasis
|
||||||||||||||
6 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬AMPK signaling pathway
|
Copanlisib Copanlisib 💬AMPK signaling pathway
| Copanlisib | 121 [1] 121 💬6. AMPK signaling pathway
|
||||||||||||||
7 | Apoptosis 💬 17 genes, 31 drugs (DrugBank) and 64 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Apoptosis
|
Copanlisib Copanlisib 💬Apoptosis
| Copanlisib | 121 [1] 121 💬7. Apoptosis
|
||||||||||||||
8 | Autophagy - animal 💬 14 genes, 20 drugs (DrugBank) and 67 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Autophagy - animal
|
Copanlisib Copanlisib 💬Autophagy - animal
| Copanlisib | 121 [1] 121 💬8. Autophagy - animal
|
||||||||||||||
9 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Axon guidance
|
Copanlisib Copanlisib 💬Axon guidance
| Copanlisib | 121 [1] 121 💬9. Axon guidance
|
||||||||||||||
10 | B cell receptor signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 68 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬B cell receptor signaling pathway
|
Copanlisib Copanlisib 💬B cell receptor signaling pathway
| Copanlisib | 121 [1] 121 💬10. B cell receptor signaling pathway
|
||||||||||||||
11 | Bacterial invasion of epithelial cells 💬 7 genes, 10 drugs (DrugBank) and 19 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Bacterial invasion of epithelial cells
|
Copanlisib Copanlisib 💬Bacterial invasion of epithelial cells
| Copanlisib | 121 [1] 121 💬11. Bacterial invasion of epithelial cells
|
||||||||||||||
12 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Breast cancer
|
Copanlisib Copanlisib 💬Breast cancer
| Copanlisib | 121 [1] 121 💬12. Breast cancer
|
||||||||||||||
13 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬C-type lectin receptor signaling pathway
|
Copanlisib Copanlisib 💬C-type lectin receptor signaling pathway
| Copanlisib | 121 [1] 121 💬13. C-type lectin receptor signaling pathway
|
||||||||||||||
14 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬cAMP signaling pathway
|
Copanlisib Copanlisib 💬cAMP signaling pathway
| Copanlisib | 121 [1] 121 💬14. cAMP signaling pathway
|
||||||||||||||
15 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Carbohydrate digestion and absorption
|
Copanlisib Copanlisib 💬Carbohydrate digestion and absorption
| Copanlisib | 121 [1] 121 💬15. Carbohydrate digestion and absorption
|
||||||||||||||
16 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Cellular senescence
|
Copanlisib Copanlisib 💬Cellular senescence
| Copanlisib | 121 [1] 121 💬16. Cellular senescence
|
||||||||||||||
17 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Central carbon metabolism in cancer
|
Copanlisib Copanlisib 💬Central carbon metabolism in cancer
| Copanlisib | 121 [1] 121 💬17. Central carbon metabolism in cancer
|
||||||||||||||
18 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Chagas disease
|
Copanlisib Copanlisib 💬Chagas disease
| Copanlisib | 121 [1] 121 💬18. Chagas disease
|
||||||||||||||
19 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Chemical carcinogenesis - reactive oxygen species
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - reactive oxygen species
| Copanlisib | 121 [1] 121 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||
20 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Chemical carcinogenesis - receptor activation
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - receptor activation
| Copanlisib | 121 [1] 121 💬20. Chemical carcinogenesis - receptor activation
|
||||||||||||||
21 | Chemokine signaling pathway 💬 23 genes, 38 drugs (DrugBank) and 64 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Chemokine signaling pathway
|
Copanlisib Copanlisib 💬Chemokine signaling pathway
| Copanlisib | 121 [1] 121 💬21. Chemokine signaling pathway
|
||||||||||||||
22 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Choline metabolism in cancer
|
Copanlisib Copanlisib 💬Choline metabolism in cancer
| Copanlisib | 121 [1] 121 💬22. Choline metabolism in cancer
|
||||||||||||||
23 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Cholinergic synapse
|
Copanlisib Copanlisib 💬Cholinergic synapse
| Copanlisib | 121 [1] 121 💬23. Cholinergic synapse
|
||||||||||||||
24 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Chronic myeloid leukemia
|
Copanlisib Copanlisib 💬Chronic myeloid leukemia
| Copanlisib | 121 [1] 121 💬24. Chronic myeloid leukemia
|
||||||||||||||
25 | Colorectal cancer 💬 14 genes, 26 drugs (DrugBank) and 59 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Colorectal cancer
|
Copanlisib Copanlisib 💬Colorectal cancer
| Copanlisib | 121 [1] 121 💬25. Colorectal cancer
|
||||||||||||||
26 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Coronavirus disease - COVID-19
|
Copanlisib Copanlisib 💬Coronavirus disease - COVID-19
| Copanlisib | 121 [1] 121 💬26. Coronavirus disease - COVID-19
|
||||||||||||||
27 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Diabetic cardiomyopathy
|
Copanlisib Copanlisib 💬Diabetic cardiomyopathy
| Copanlisib | 121 [1] 121 💬27. Diabetic cardiomyopathy
|
||||||||||||||
28 | Endometrial cancer 💬 10 genes, 20 drugs (DrugBank) and 28 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Endometrial cancer
|
Copanlisib Copanlisib 💬Endometrial cancer
| Copanlisib | 121 [1] 121 💬28. Endometrial cancer
|
||||||||||||||
29 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Epstein-Barr virus infection
|
Copanlisib Copanlisib 💬Epstein-Barr virus infection
| Copanlisib | 121 [1] 121 💬29. Epstein-Barr virus infection
|
||||||||||||||
30 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬ErbB signaling pathway
|
Copanlisib Copanlisib 💬ErbB signaling pathway
| Copanlisib | 121 [1] 121 💬30. ErbB signaling pathway
|
||||||||||||||
31 | Estrogen signaling pathway 💬 21 genes, 81 drugs (DrugBank) and 73 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Estrogen signaling pathway
|
Copanlisib Copanlisib 💬Estrogen signaling pathway
| Copanlisib | 121 [1] 121 💬31. Estrogen signaling pathway
|
||||||||||||||
32 | Fc epsilon RI signaling pathway 💬 19 genes, 50 drugs (DrugBank) and 68 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Fc epsilon RI signaling pathway
|
Copanlisib Copanlisib 💬Fc epsilon RI signaling pathway
| Copanlisib | 121 [1] 121 💬32. Fc epsilon RI signaling pathway
|
||||||||||||||
33 | Fc gamma R-mediated phagocytosis 💬 9 genes, 14 drugs (DrugBank) and 20 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Fc gamma R-mediated phagocytosis
|
Copanlisib Copanlisib 💬Fc gamma R-mediated phagocytosis
| Copanlisib | 121 [1] 121 💬33. Fc gamma R-mediated phagocytosis
|
||||||||||||||
34 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Fluid shear stress and atherosclerosis
|
Copanlisib Copanlisib 💬Fluid shear stress and atherosclerosis
| Copanlisib | 121 [1] 121 💬34. Fluid shear stress and atherosclerosis
|
||||||||||||||
35 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Focal adhesion
|
Copanlisib Copanlisib 💬Focal adhesion
| Copanlisib | 121 [1] 121 💬35. Focal adhesion
|
||||||||||||||
36 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬FoxO signaling pathway
|
Copanlisib Copanlisib 💬FoxO signaling pathway
| Copanlisib | 121 [1] 121 💬36. FoxO signaling pathway
|
||||||||||||||
37 | Gastric cancer 💬 22 genes, 40 drugs (DrugBank) and 66 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Gastric cancer
|
Copanlisib Copanlisib 💬Gastric cancer
| Copanlisib | 121 [1] 121 💬37. Gastric cancer
|
||||||||||||||
38 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Glioma
|
Copanlisib Copanlisib 💬Glioma
| Copanlisib | 121 [1] 121 💬38. Glioma
|
||||||||||||||
39 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬GnRH secretion
|
Copanlisib Copanlisib 💬GnRH secretion
| Copanlisib | 121 [1] 121 💬39. GnRH secretion
|
||||||||||||||
40 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Growth hormone synthesis, secretion and action
|
Copanlisib Copanlisib 💬Growth hormone synthesis, secretion and action
| Copanlisib | 121 [1] 121 💬40. Growth hormone synthesis, secretion and action
|
||||||||||||||
41 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Hepatitis B
|
Copanlisib Copanlisib 💬Hepatitis B
| Copanlisib | 121 [1] 121 💬41. Hepatitis B
|
||||||||||||||
42 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Hepatitis C
|
Copanlisib Copanlisib 💬Hepatitis C
| Copanlisib | 121 [1] 121 💬42. Hepatitis C
|
||||||||||||||
43 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Hepatocellular carcinoma
|
Copanlisib Copanlisib 💬Hepatocellular carcinoma
| Copanlisib | 121 [1] 121 💬43. Hepatocellular carcinoma
|
||||||||||||||
44 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Herpes simplex virus 1 infection
|
Copanlisib Copanlisib 💬Herpes simplex virus 1 infection
| Copanlisib | 121 [1] 121 💬44. Herpes simplex virus 1 infection
|
||||||||||||||
45 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬HIF-1 signaling pathway
|
Copanlisib Copanlisib 💬HIF-1 signaling pathway
| Copanlisib | 121 [1] 121 💬45. HIF-1 signaling pathway
|
||||||||||||||
46 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Hormone signaling
|
Copanlisib Copanlisib 💬Hormone signaling
| Copanlisib | 121 [1] 121 💬46. Hormone signaling
|
||||||||||||||
47 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Human cytomegalovirus infection
|
Copanlisib Copanlisib 💬Human cytomegalovirus infection
| Copanlisib | 121 [1] 121 💬47. Human cytomegalovirus infection
|
||||||||||||||
48 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Human immunodeficiency virus 1 infection
|
Copanlisib Copanlisib 💬Human immunodeficiency virus 1 infection
| Copanlisib | 121 [1] 121 💬48. Human immunodeficiency virus 1 infection
|
||||||||||||||
49 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Human papillomavirus infection
|
Copanlisib Copanlisib 💬Human papillomavirus infection
| Copanlisib | 121 [1] 121 💬49. Human papillomavirus infection
|
||||||||||||||
50 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Human T-cell leukemia virus 1 infection
|
Copanlisib Copanlisib 💬Human T-cell leukemia virus 1 infection
| Copanlisib | 121 [1] 121 💬50. Human T-cell leukemia virus 1 infection
|
||||||||||||||
51 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Inflammatory mediator regulation of TRP channels
|
Copanlisib Copanlisib 💬Inflammatory mediator regulation of TRP channels
| Copanlisib | 121 [1] 121 💬51. Inflammatory mediator regulation of TRP channels
|
||||||||||||||
52 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Influenza A
|
Copanlisib Copanlisib 💬Influenza A
| Copanlisib | 121 [1] 121 💬52. Influenza A
|
||||||||||||||
53 | Inositol phosphate metabolism 💬 4 genes, 5 drugs (DrugBank) and 10 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Inositol phosphate metabolism
|
Copanlisib Copanlisib 💬Inositol phosphate metabolism
| Copanlisib | 121 [1] 121 💬53. Inositol phosphate metabolism
|
||||||||||||||
54 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Insulin resistance
|
Copanlisib Copanlisib 💬Insulin resistance
| Copanlisib | 121 [1] 121 💬54. Insulin resistance
|
||||||||||||||
55 | Insulin signaling pathway 💬 12 genes, 28 drugs (DrugBank) and 71 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Insulin signaling pathway
|
Copanlisib Copanlisib 💬Insulin signaling pathway
| Copanlisib | 121 [1] 121 💬55. Insulin signaling pathway
|
||||||||||||||
56 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬JAK-STAT signaling pathway
|
Copanlisib Copanlisib 💬JAK-STAT signaling pathway
| Copanlisib | 121 [1] 121 💬56. JAK-STAT signaling pathway
|
||||||||||||||
57 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Kaposi sarcoma-associated herpesvirus infection
|
Copanlisib Copanlisib 💬Kaposi sarcoma-associated herpesvirus infection
| Copanlisib | 121 [1] 121 💬57. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||
58 | Leukocyte transendothelial migration 💬 18 genes, 23 drugs (DrugBank) and 44 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Leukocyte transendothelial migration
|
Copanlisib Copanlisib 💬Leukocyte transendothelial migration
| Copanlisib | 121 [1] 121 💬58. Leukocyte transendothelial migration
|
||||||||||||||
59 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Lipid and atherosclerosis
|
Copanlisib Copanlisib 💬Lipid and atherosclerosis
| Copanlisib | 121 [1] 121 💬59. Lipid and atherosclerosis
|
||||||||||||||
60 | Longevity regulating pathway 💬 11 genes, 22 drugs (DrugBank) and 71 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Longevity regulating pathway
|
Copanlisib Copanlisib 💬Longevity regulating pathway
| Copanlisib | 121 [1] 121 💬60. Longevity regulating pathway
|
||||||||||||||
61 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 66 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Longevity regulating pathway - multiple species
|
Copanlisib Copanlisib 💬Longevity regulating pathway - multiple species
| Copanlisib | 121 [1] 121 💬61. Longevity regulating pathway - multiple species
|
||||||||||||||
62 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Measles
|
Copanlisib Copanlisib 💬Measles
| Copanlisib | 121 [1] 121 💬62. Measles
|
||||||||||||||
63 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Melanoma
|
Copanlisib Copanlisib 💬Melanoma
| Copanlisib | 121 [1] 121 💬63. Melanoma
|
||||||||||||||
64 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬MicroRNAs in cancer
|
Copanlisib Copanlisib 💬MicroRNAs in cancer
| Copanlisib | 121 [1] 121 💬64. MicroRNAs in cancer
|
||||||||||||||
65 | mTOR signaling pathway 💬 14 genes, 33 drugs (DrugBank) and 95 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬mTOR signaling pathway
|
Copanlisib Copanlisib 💬mTOR signaling pathway
| Copanlisib | 121 [1] 121 💬65. mTOR signaling pathway
|
||||||||||||||
66 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Natural killer cell mediated cytotoxicity
|
Copanlisib Copanlisib 💬Natural killer cell mediated cytotoxicity
| Copanlisib | 121 [1] 121 💬66. Natural killer cell mediated cytotoxicity
|
||||||||||||||
67 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Neuroactive ligand signaling
| Desipramine | 121 [1] 121 💬67. Neuroactive ligand signaling
|
||||||||||||||
68 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Neuroactive ligand signaling
| Desipramine | 121 [1] 121 💬67. Neuroactive ligand signaling
|
||||||||||||||
69 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Neurotrophin signaling pathway
|
Copanlisib Copanlisib 💬Neurotrophin signaling pathway
| Copanlisib | 121 [1] 121 💬69. Neurotrophin signaling pathway
|
||||||||||||||
70 | Neutrophil extracellular trap formation 💬 36 genes, 46 drugs (DrugBank) and 77 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Neutrophil extracellular trap formation
|
Copanlisib Copanlisib 💬Neutrophil extracellular trap formation
| Copanlisib | 121 [1] 121 💬70. Neutrophil extracellular trap formation
|
||||||||||||||
71 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Non-alcoholic fatty liver disease
|
Copanlisib Copanlisib 💬Non-alcoholic fatty liver disease
| Copanlisib | 121 [1] 121 💬71. Non-alcoholic fatty liver disease
|
||||||||||||||
72 | Non-small cell lung cancer 💬 21 genes, 40 drugs (DrugBank) and 58 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Non-small cell lung cancer
|
Copanlisib Copanlisib 💬Non-small cell lung cancer
| Copanlisib | 121 [1] 121 💬72. Non-small cell lung cancer
|
||||||||||||||
73 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Osteoclast differentiation
|
Copanlisib Copanlisib 💬Osteoclast differentiation
| Copanlisib | 121 [1] 121 💬73. Osteoclast differentiation
|
||||||||||||||
74 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Pancreatic cancer
|
Copanlisib Copanlisib 💬Pancreatic cancer
| Copanlisib | 121 [1] 121 💬74. Pancreatic cancer
|
||||||||||||||
75 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Pathways in cancer
|
Copanlisib Copanlisib 💬Pathways in cancer
| Copanlisib | 121 [1] 121 💬75. Pathways in cancer
|
||||||||||||||
76 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Copanlisib Copanlisib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Copanlisib | 121 [1] 121 💬76. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||
77 | Phosphatidylinositol signaling system 💬 5 genes, 6 drugs (DrugBank) and 11 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Phosphatidylinositol signaling system
|
Copanlisib Copanlisib 💬Phosphatidylinositol signaling system
| Copanlisib | 121 [1] 121 💬77. Phosphatidylinositol signaling system
|
||||||||||||||
78 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Phospholipase D signaling pathway
|
Copanlisib Copanlisib 💬Phospholipase D signaling pathway
| Copanlisib | 121 [1] 121 💬78. Phospholipase D signaling pathway
|
||||||||||||||
79 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬PI3K-Akt signaling pathway
|
Copanlisib Copanlisib 💬PI3K-Akt signaling pathway
| Copanlisib | 121 [1] 121 💬79. PI3K-Akt signaling pathway
|
||||||||||||||
80 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Platelet activation
|
Copanlisib Copanlisib 💬Platelet activation
| Copanlisib | 121 [1] 121 💬80. Platelet activation
|
||||||||||||||
81 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Prion disease
|
Copanlisib Copanlisib 💬Prion disease
| Copanlisib | 121 [1] 121 💬81. Prion disease
|
||||||||||||||
82 | Progesterone-mediated oocyte maturation 💬 14 genes, 38 drugs (DrugBank) and 46 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Progesterone-mediated oocyte maturation
|
Copanlisib Copanlisib 💬Progesterone-mediated oocyte maturation
| Copanlisib | 121 [1] 121 💬82. Progesterone-mediated oocyte maturation
|
||||||||||||||
83 | Prolactin signaling pathway 💬 19 genes, 43 drugs (DrugBank) and 70 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Prolactin signaling pathway
|
Copanlisib Copanlisib 💬Prolactin signaling pathway
| Copanlisib | 121 [1] 121 💬83. Prolactin signaling pathway
|
||||||||||||||
84 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Prostate cancer
|
Copanlisib Copanlisib 💬Prostate cancer
| Copanlisib | 121 [1] 121 💬84. Prostate cancer
|
||||||||||||||
85 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Proteoglycans in cancer
|
Copanlisib Copanlisib 💬Proteoglycans in cancer
| Copanlisib | 121 [1] 121 💬85. Proteoglycans in cancer
|
||||||||||||||
86 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Rap1 signaling pathway
|
Copanlisib Copanlisib 💬Rap1 signaling pathway
| Copanlisib | 121 [1] 121 💬86. Rap1 signaling pathway
|
||||||||||||||
87 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Ras signaling pathway
|
Copanlisib Copanlisib 💬Ras signaling pathway
| Copanlisib | 121 [1] 121 💬87. Ras signaling pathway
|
||||||||||||||
88 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Regulation of actin cytoskeleton
|
Copanlisib Copanlisib 💬Regulation of actin cytoskeleton
| Copanlisib | 121 [1] 121 💬88. Regulation of actin cytoskeleton
|
||||||||||||||
89 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Regulation of lipolysis in adipocytes
|
Copanlisib Copanlisib 💬Regulation of lipolysis in adipocytes
| Copanlisib | 121 [1] 121 💬89. Regulation of lipolysis in adipocytes
|
||||||||||||||
90 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Relaxin signaling pathway
|
Copanlisib Copanlisib 💬Relaxin signaling pathway
| Copanlisib | 121 [1] 121 💬90. Relaxin signaling pathway
|
||||||||||||||
91 | Renal cell carcinoma 💬 12 genes, 16 drugs (DrugBank) and 26 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Renal cell carcinoma
|
Copanlisib Copanlisib 💬Renal cell carcinoma
| Copanlisib | 121 [1] 121 💬91. Renal cell carcinoma
|
||||||||||||||
92 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Salmonella infection
|
Copanlisib Copanlisib 💬Salmonella infection
| Copanlisib | 121 [1] 121 💬92. Salmonella infection
|
||||||||||||||
93 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
SLC6A4 [1] SLC6A4 💬Serotonergic synapse
|
Desipramine hydrochloride Desipramine hydrochloride 💬Serotonergic synapse
| Desipramine | 121 [1] 121 💬93. Serotonergic synapse
|
||||||||||||||
94 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
SLC6A4 [1] SLC6A4 💬Serotonergic synapse
|
Desipramine Desipramine 💬Serotonergic synapse
| Desipramine | 121 [1] 121 💬93. Serotonergic synapse
|
||||||||||||||
95 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Shigellosis
|
Copanlisib Copanlisib 💬Shigellosis
| Copanlisib | 121 [1] 121 💬95. Shigellosis
|
||||||||||||||
96 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 36 drugs (DrugBank) and 62 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Signaling pathways regulating pluripotency of stem cells
|
Copanlisib Copanlisib 💬Signaling pathways regulating pluripotency of stem cells
| Copanlisib | 121 [1] 121 💬96. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||
97 | Small cell lung cancer 💬 16 genes, 43 drugs (DrugBank) and 64 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Small cell lung cancer
|
Copanlisib Copanlisib 💬Small cell lung cancer
| Copanlisib | 121 [1] 121 💬97. Small cell lung cancer
|
||||||||||||||
98 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Sphingolipid signaling pathway
|
Copanlisib Copanlisib 💬Sphingolipid signaling pathway
| Copanlisib | 121 [1] 121 💬98. Sphingolipid signaling pathway
|
||||||||||||||
99 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Spinocerebellar ataxia
|
Copanlisib Copanlisib 💬Spinocerebellar ataxia
| Copanlisib | 121 [1] 121 💬99. Spinocerebellar ataxia
|
||||||||||||||
100 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Synaptic vesicle cycle
| Desipramine | 121 [1] 121 💬100. Synaptic vesicle cycle
|
||||||||||||||
101 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Synaptic vesicle cycle
| Desipramine | 121 [1] 121 💬100. Synaptic vesicle cycle
|
||||||||||||||
102 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬T cell receptor signaling pathway
|
Copanlisib Copanlisib 💬T cell receptor signaling pathway
| Copanlisib | 121 [1] 121 💬102. T cell receptor signaling pathway
|
||||||||||||||
103 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Thyroid hormone signaling pathway
|
Copanlisib Copanlisib 💬Thyroid hormone signaling pathway
| Copanlisib | 121 [1] 121 💬103. Thyroid hormone signaling pathway
|
||||||||||||||
104 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬TNF signaling pathway
|
Copanlisib Copanlisib 💬TNF signaling pathway
| Copanlisib | 121 [1] 121 💬104. TNF signaling pathway
|
||||||||||||||
105 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Toll-like receptor signaling pathway
|
Copanlisib Copanlisib 💬Toll-like receptor signaling pathway
| Copanlisib | 121 [1] 121 💬105. Toll-like receptor signaling pathway
|
||||||||||||||
106 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Type II diabetes mellitus
|
Copanlisib Copanlisib 💬Type II diabetes mellitus
| Copanlisib | 121 [1] 121 💬106. Type II diabetes mellitus
|
||||||||||||||
107 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬VEGF signaling pathway
|
Copanlisib Copanlisib 💬VEGF signaling pathway
| Copanlisib | 121 [1] 121 💬107. VEGF signaling pathway
|
||||||||||||||
108 | Viral carcinogenesis 💬 32 genes, 31 drugs (DrugBank) and 58 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Viral carcinogenesis
|
Copanlisib Copanlisib 💬Viral carcinogenesis
| Copanlisib | 121 [1] 121 💬108. Viral carcinogenesis
|
||||||||||||||
109 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Yersinia infection
|
Copanlisib Copanlisib 💬Yersinia infection
| Copanlisib | 121 [1] 121 💬109. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 30 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 71 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Apoptosis
17 genes, 31 drugs (DrugBank) and 64 diseases
Autophagy - animal
14 genes, 20 drugs (DrugBank) and 67 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
B cell receptor signaling pathway
19 genes, 39 drugs (DrugBank) and 68 diseases
Bacterial invasion of epithelial cells
7 genes, 10 drugs (DrugBank) and 19 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Chemokine signaling pathway
23 genes, 38 drugs (DrugBank) and 64 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Chronic myeloid leukemia
17 genes, 23 drugs (DrugBank) and 36 diseases
Colorectal cancer
14 genes, 26 drugs (DrugBank) and 59 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Endometrial cancer
10 genes, 20 drugs (DrugBank) and 28 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Estrogen signaling pathway
21 genes, 81 drugs (DrugBank) and 73 diseases
Fc epsilon RI signaling pathway
19 genes, 50 drugs (DrugBank) and 68 diseases
Fc gamma R-mediated phagocytosis
9 genes, 14 drugs (DrugBank) and 20 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
FoxO signaling pathway
25 genes, 43 drugs (DrugBank) and 60 diseases
Gastric cancer
22 genes, 40 drugs (DrugBank) and 66 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hepatitis B
43 genes, 65 drugs (DrugBank) and 87 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Hepatocellular carcinoma
21 genes, 32 drugs (DrugBank) and 67 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human immunodeficiency virus 1 infection
50 genes, 57 drugs (DrugBank) and 95 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Inflammatory mediator regulation of TRP channels
25 genes, 53 drugs (DrugBank) and 65 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
Inositol phosphate metabolism
4 genes, 5 drugs (DrugBank) and 10 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Insulin signaling pathway
12 genes, 28 drugs (DrugBank) and 71 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leukocyte transendothelial migration
18 genes, 23 drugs (DrugBank) and 44 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Longevity regulating pathway
11 genes, 22 drugs (DrugBank) and 71 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 66 diseases
Measles
42 genes, 63 drugs (DrugBank) and 68 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
mTOR signaling pathway
14 genes, 33 drugs (DrugBank) and 95 diseases
Natural killer cell mediated cytotoxicity
44 genes, 50 drugs (DrugBank) and 86 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 37 diseases
Neutrophil extracellular trap formation
36 genes, 46 drugs (DrugBank) and 77 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Non-small cell lung cancer
21 genes, 40 drugs (DrugBank) and 58 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
35 genes, 66 drugs (DrugBank) and 100 diseases
Phosphatidylinositol signaling system
5 genes, 6 drugs (DrugBank) and 11 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Platelet activation
25 genes, 67 drugs (DrugBank) and 64 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Progesterone-mediated oocyte maturation
14 genes, 38 drugs (DrugBank) and 46 diseases
Prolactin signaling pathway
19 genes, 43 drugs (DrugBank) and 70 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renal cell carcinoma
12 genes, 16 drugs (DrugBank) and 26 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Shigellosis
29 genes, 51 drugs (DrugBank) and 92 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 36 drugs (DrugBank) and 62 diseases
Small cell lung cancer
16 genes, 43 drugs (DrugBank) and 64 diseases
Sphingolipid signaling pathway
32 genes, 57 drugs (DrugBank) and 80 diseases
Spinocerebellar ataxia
18 genes, 29 drugs (DrugBank) and 74 diseases
Synaptic vesicle cycle
8 genes, 34 drugs (DrugBank) and 42 diseases
T cell receptor signaling pathway
38 genes, 59 drugs (DrugBank) and 84 diseases
Thyroid hormone signaling pathway
25 genes, 45 drugs (DrugBank) and 73 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral carcinogenesis
32 genes, 31 drugs (DrugBank) and 58 diseases
Yersinia infection
27 genes, 45 drugs (DrugBank) and 79 diseases